References

REFERENCES

1. American Diabetes Association. Diabetes Statistics. Alexandria, VA: American Diabetes Association, 2006.
   
2. American Diabetes Association. Medical Management of Type 2 Diabetes. Alexandria, VA: American Diabetes Association, 1998.
   
3. Diabetes Research Working Group. Congressional report on National Institutes of Health implementation of the recommendations of the Congressionally-directed Diabetes Research Working Group, 1998.
   
4. Mokdad AH, Ford ES. Diabetes trends in the U.S.: 1990 - 1998. Diabetes Care 2000; 23:1278 - 83.
   
5. Ogden CL, Carroll MD. Prevalence of overweight and obesity in the United States, 1999 - 2004. JAMA 2006; 295:1549 - 55.
   
6. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999 - 2000. JAMA 2002; 288:1723 - 7.
   
7. Tan AS, Brietzke SA, Gardner OW, Sowers JR. In: Mantzoros CS, ed. Obesity, Diabetes, and Hypertension. Totowa, NJ: Humana Press Inc., 2006:169 - 92.
   
8. Nestle M, Jacobson MF. Halting the obesity epidemic: a public health policy approach. Public Health Rep 2000; 115:12 - 24.
   
9. Federation of American Societies for Experimental Biology, LSRO. Executive summary from the third report on nutrition monitoring in the United States. J Nutr 1996; 126:1907S - 36.
   
10. Schumann M. Megabrands: top brands hold the line in 2001. Advertising Age 2002; S1 - 9:200 - 12.
    
11. USDA. 1994 - 96 Continuing survey of food intakes by individuals. USDA 2002:10 - 7.
    
12. Battle EK, Brownell KD. Confronting a rising tide of eating disorders and obesity: treatment vs. prevention and policy. Addict Behav 1996; 21:755 - 65.
    
13. Burros M. Losing count of calories as plates fill up. New York Times 2 April 1997; Section C:4.
    
14. Bar-Or O, Foreyt J. Physical activity, genetic, and nutritional considerations in childhood weight management. Med Sci Sports Exerc 1998; 30:2 - 10.
    
15. USDA. Data tables: Results from USDAs 1994 - 96. Continuing Survey of Food Intakes by Individuals and 1994 - 96 Diet and Health Knowledge Survey. USDA 1997.
    
16. World Health Organization. Obesity: preventing and managing a global epidemic. Report of a WHO Consultation. 2000. Geneva, WHO: WHO Technical Report Series 894. 1999.
    
17. Tufts University. Special Report: Portion Distortion. Tufts University Health & Nutrition Newsletter 2002; 18:4 - 5.
    
18. Center for Disease Control. Trends in intake of energy and macronutrients - United States, 1971 - 2000. CDC 2004; 11 - 8 - 2006.
    
19. Wylie-Rosett J, Herman WH, Goldberg RB. Lifestyle intervention to prevent diabetes: intensive and cost effective. Curr Opin Lipidol 2006; 17:37 - 44.
    
20. Pan XR, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20:537 - 44.
    
21. Tuomilehto J, Lindstrom J. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344:1343 - 50.
    
22. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:403.
    
23. Hamman RF, Wing RR. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care 2006; 29:2102 - 7.
    
24. Bradley C. Handbook of Psychology and Diabetes: A Guide to Psychological Measurement in Diabetes Research and Practice. London: Harwood Academic Publishers, 1994.
    
25. Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev 1999; 15:205 - 18.
    
26. Snoek FJ, Skinner TC. Psychology in Diabetes Care. New York: John Wiley & Sons, 2000.
    
27. Glasgow RE, Hiss RG. Report of the health care delivery work group: behavioral research related to the establishment of a chronic disease model for diabetes care. Diabetes Care 2001; 24:124 - 30.
    
28. Rubin RR, Peyrot M. Psychological issues and treatments for people with diabetes. J Clin Psychol 2001; 57:457 - 78.
    
29. Jacobson AM. The psychological care of patients with insulin-dependent diabetes mellitus. N Engl J Med 1996; 334:1249 - 53.
    
30. Rubin RR. Counselling and Psychotherapy in Diabetes Mellitus. In: Snoek FJ, Skinner TJ, eds. Psychology in Diabetes Care. New York, NY: Wiley, 2000:235 - 63.
    
31. Funnell MF, Anderson RM. Patient Empowerment. In: Snoek FJ, ST eds. Psychology in Diabetes Care. New York: Wiley, 2000.
    
32. Polonsky WH. Diabetes burnout. What to do when you can't take it anymore. Alexandria, VA: American Diabetes Association, 2000.
    
33. Day JL. Diabetic patient education: determinants of success. Diabetes Metab Res Rev 2000; 16 (Suppl. 1):S70 - 4.
    
34. Jacobson AM, de Groot M, Samson JA. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care 1994; 17:267 - 74.
    
35. Glasgow RE. Medical Office-Based Interventions. In: Snoek FJ, Skinner TC, eds. Psychology in Diabetes Care. New York, NY: Wiley, 2000:141 - 68.
    
36. Clark M, Asimakopoulou K. Diabetes in Older Adults. In: Snoek FJ, Skinner TC, eds. Psychology in Diabetes Care. New York, NY: Wiley, 2000.
    
37. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications with type 2 diabetes (UKPDS). Lancet 1998; 352:837 - 53.
    
38. Welch GW, Jacobson AM, Polonsky WH. The problem areas in diabetes scale. An evaluation of its clinical utility. Diabetes Care 1998; 20:760 - 6.
    
39. Snoek FJ, Pouwer F, Welch GW, Polonsky WH. Diabetes-related emotional distress in Dutch and U.S. diabetic patients: cross-cultural validity of the problem areas in diabetes scale. Diabetes Care 2000; 23:1305 - 9.
    
40. Welch GW, de Groot M, Buckland GT, Chipkin S. Risk stratification of diabetes patients using diet barriers and self care motivation in an inner city hospital setting. Diabetes 1999; 48(Suppl).
    
41. Polonsky WH, Anderson BJ. Assessment of diabetes-related emotional distress. Diabetes Care 1995; 18:754 - 60.
    
42. Peyrot M, Rubin RR. Psychosocial problems and barriers to improved diabetes management: results of the cross-national diabetes attitudes, wishes and needs (DAWN) Study. Diabet Med 2005; 22:1379 - 85.
    
43. Delamater AM, Cox DJ. Psychological stress, coping, and diabetes. Diabetes Spect 1994; 7:46 - 9.
    
44. Surwit RS, Schneider MS. Role of stress in the etiology and treatment of diabetes mellitus. Psychosom Med 1993; 55:380 - 93.
    
45. Surwit RS, Schneider MS, Feinglos MN. Stress and diabetes mellitus. Diabetes Care 1992; 15:1413 - 22.
    
46. Peyrot MF, McMurry JF Jr. Stress buffering and glycemic control. The role of coping styles. Diabetes Care 1992; 15:842 - 6.
    
47. Aikens JE, Kiolbasa TA, Sobel R. Psychological predictors of glycemic change with relaxation training in non-insulin-dependent diabetes mellitus. Psychother. Psychosom 1997; 66:302 - 6.
    
48. Cohen ST, Welch G, Jacobson AM, de Groot M, Samson J. The association of lifetime psychiatric illness and increased retinopathy in patients with type I diabetes mellitus. Psychosomatics 1997; 38: 98 - 108.
    
49. Crow S, Kendall D, Praus B, Thuras P. Binge eating and other psychopathology in patients with type 2 diabetes mellitus. Int J Eat Dis 2001; 30:222 - 6.
    
50. Pouwer F, Beekman AT. Rates and risks for co-morbid depression in patients with type 2 diabetes mellitus: results from a community-based study. Diabetologia 2003; 46:892 - 98.
    
51. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001; 24:1069 - 78.
    
52. Wells KB, Golding JM, Burnam MA. Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry 1988; 145:976 - 81.
    
53. Lustman PJ, Griffith LS. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 1997; 59:241 - 50.
    
54. Mazze RS, Lucido D, Shamoon H. Psychological and social correlates of glycemic control. Diabetes Care 1984; 7:360 - 6.
    
55. de Groot M, Jacobson AM, Samson JA, Welch G. Glycemic control and major depression in patients with type 1 and type 2 diabetes mellitus. J Psychosom Res 1984; 46:425 - 35.
    
56. Lustman PJ, Griffith LS, Freedland KE, Clouse RE. The course of major depression in diabetes. Gen Hosp Psychiatry 1997; 19:138 - 43.
    
57. Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE. Cognitive behavior therapy for depression in type 2 diabetes mellitus: a randomized, controlled trial. Ann Intern Med 1998; 129:613 - 21.
    
58. Kawakami N, Takatsuka N, Shimizu H, Ishibashi H. Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care 1999; 22:1071 - 6.
    
59. Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE. Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care 1996; 19:1097 - 102.
    
60. Arroyo C, Hu FB. Depressive symptoms and risk of type 2 diabetes in women. Diabetes Care 2004; 27:129 - 33.
    
61. Golden SH, Williams JE. Depressive symptoms and the risk of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes Care 2004; 27:429 - 35.
    
62. Lustman PJ, Freedland KE, Griffith LS, Clouse RE. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care 2000; 23:618 - 23.
    
63. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001; 63:619 - 30.
    
64. Kroenke K. Discovering depression in medical patients: reasonable expectations. Ann Intern Med 1997; 126:463 - 5.
    
65. Williams JW Jr, Mulrow CD. Case-finding for depression in primary care: a randomized trial. Am J Med 1999; 106:36 - 43.
    
66. De Groot M, Jacobson AM, Samson JA. Psychiatric illness in patients with type 1 and type 2 diabetes mellitus. Psychosom Med 1994; 56:176A.
    
67. Peyrot M, Rubin RR. Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care 1997; 20:585 - 90.
    
68. Green L, Feher M, Catalan J. Fears and phobias in people with diabetes. Diabetes Metab Res Rev 2000; 16:287 - 93.
    
69. Surwit RS, van Tilburg MA. Stress management improves long-term glycemic control in type 2 diabetes. Diabetes Care 2002; 25:30 - 4.
    
70. Yoo JS, Kim EJ, Lee SJ. The effects of a comprehensive life style modification program on glycemic control and stress response in type 2 diabetes. Taehan Kanho Hakhoe Chi 2006; 36:751 - 60.
    
71. Okada S, Ichiki K. Effect of an anxiolytic on lipid profile in non-insulin-dependent diabetes mellitus. J Int Med Res 1994; 22:338 - 42.
    
72. Lustman PJ, Griffith LS. Effects of alprazolam on glucose regulation in diabetes. Results of double-blind, placebo-controlled trial. Diabetes Care 1995; 18:1133 - 9.
    
73. Svacina S. Our experience with antidepressant treatment in the obese and type 2 diabetics. Prague Med Rep 2005; 106:291 - 6.
    
74. Cox D, Gonder-Frederick L. A multicenter evaluation of blood glucose awareness training-II. Diabetes Care 1995; 18:523 - 8.
    
75. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association, 1994.
    
76. Stinson FS, Grant BF. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend 2005; 80:105 - 16.
    
77. McQuade WH, Levy SM, Yanek LR, Davis SW, Liepman MR. Detecting symptoms of alcohol abuse in primary care settings. Arch Fam Med 2000; 9:814 - 21.
    
78. Avogaro A, Tiengo A. Alcohol, glucose metabolism and diabetes. Diabetes Metab Rev 1993; 9: 129 - 46.
    
79. National Institute on Alcohol Abuse and Alcoholism. Eighth Special Report to the U.S. Congress on Alcohol and Health. Washington, DC: Secretary of Health and Human Services, 1993.
    
80. Emanuele NV, Swade TF, Emanuele MA. Consequences of alcohol use in diabetics. Alcohol Health Res World 1998; 22:211 - 9.
    
81. Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA 1984; 252:1905 - 7.
    
82. National Institute of Mental Health. Eating disorders: facts about eating disorders and the search for solutions. NIH Publication No. P01 4901 2001.
    
83. Papelbaum M, Appolinario JC. Prevalence of eating disorders and psychiatric comorbidity in a clinical sample of type 2 diabetes mellitus patients. Rev Bras Psiquiatr 2005; 27:135 - 8.
    
84. Wing RR, Nowalk MP, Marcus MD, Koeske R, Finegold D. Subclinical eating disorders and glycemic control in adolescents with type I diabetes. Diabetes Care 1986; 9:162 - 7.
    
85. Wolff GE, Clark MM. Changes in eating self-efficacy and body image following cognitive-behavioral group therapy for binge eating disorder: a clinical study. Eat Behav 2001; 2:97 - 104.
    
86. Kaplan RM, Sallis JF, Patterson TL. Health and Human Behavior. New York: McGraw-Hill, 1993.
    
87. House JS, ed. Work Stress and Social Support. Reading, MA: Addison-Wesley, 1981:13 - 40.
    
88. Lazarus RS, Folkman S. Stress, Appraisal, and Coping. New York: Springer, 1984.
    
89. Kawachi I, Colditz G. A prospective study of social networks in relation to total mortality and cardiovascular disease in men in the USA. J Epidemiol Community Health 1996; 50:245 - 51.
    
90. Weissberg-Benchell J, Pichert JW. Counseling techniques for clinicians and educators. Diabetes Spect 1999; 12(2):103 - 7.
    
91. Boehm S, Schlenk EA, Funnell MM, Powers H, Ronis DL. Predictors of adherence to nutrition recommendations in people with non-insulin-dependent diabetes mellitus. Diabetes Educ 1997; 23: 157 - 65.
    
92. Hakim LS, Goldstein I. Diabetic sexual dysfunction. Endocrinol Metab Clin North Am 1996; 25: 379 - 400.
    
93. Chu NV, Edelman SV. Erectile dysfunction and diabetes. Curr Diab Rep 2002; 2:60 - 6.
    
94. Israilov S, Shmuely J. Evaluation of a progressive treatment program for erectile dysfunction in patients with diabetes mellitus. Int J Impot Res 2005; 17:431 - 6.
    
95. Doggrell SA. Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction. Expert Opin Pharmacother 2005; 6:75 - 84.
    
96. Schreiner-Engel P, Schiavi RC, Vietorisz D, Smith H. The differential impact of diabetes type on female sexuality. J Psychosom Res 1987; 31:23 - 33.
    
97. Veves A, Webster L, Chen TF, Payne S, Boulton AJ. Aetiopathogenesis and management of impotence in diabetic males: four years experience from a combined clinic. Diabet Med 1995; 12:77 - 82.
    
98. Guay AT. Safety and tolerability of sildenafil citrate for the treatment of erectile function in men with type 1 and type 2 diabetes [abstract]. Diabetes 2000; 49(Suppl. l):363.
    
99. Boulton AJ, Selam JL, Sweeney M, Ziegler D. Sildenafil citrate for the treatment of erectile dysfunction in men with type II diabetes mellitus. Diabetologia 2001; 44:1296 - 301.
    
100. Blonde L. Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials. Curr Med Res Opin 2006; 22:2111 - 20.
     
101. Kent S. Is diabetes a form of accelerated aging? Geriatrics 1976; 31:140 - 54.
     
102. Perlmuter LC, Hakami MK. Decreased cognitive function in aging non-insulin-dependent diabetic patients. Am J Med 1984; 77:1043 - 8.
     
103. Strachan MWJ, Deary IJ, Ewing FME, Frier BM. Is type 2 (non-insulin dependent) diabetes mellitus associated with an increased risk of cognitive dysfunction? Diabetes Care 1997; 20:438 - 45.
     
104. Ryan CM, Greckle M. Why is learning and memory dysfunction in type 2 diabetes limited to older adults. Diabetes Metab Res Rev 2000; 16:308 - 15.
     
105. Debling D, Amelang M, Hasselbach P, Sturmer T. Diabetes and cognitive function in a population-based study of elderly women and men. J Diabetes Complications 2006; 20:238 - 45.
     
106. Manschot SM, Brands AM. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 2006; 55:1106 - 13.
     
107. Akisaki T, Sakurai T. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT). Diabetes Metab Res Rev 2006; 22:376 - 84.
     
108. Steen E, Terry BM. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes? J Alzheimers Dis 2005; 7:63 - 80.
     
109. Biessels GJ, Kappelle LJ. Increased risk of Alzheimer's disease in type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem Soc Trans 2005; 33:1041 - 4.
     
110. Rasgon N, Jarvik L. Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis. J Gerontol A Biol Sci Med Sci 2004; 59:178 - 83.
     
111. Craft S. Insulin resistance syndrome and Alzheimer's disease: age- and obesity-related effects on memory, amyloid, and inflammation. Neurobiol Aging 2005; 26(Suppl 1):65 - 9.
     
112. Sun MK, Alkon DL. Links between Alzheimer's disease and diabetes. Timely. top. Med Cardiovasc Dis 2006; 10:E24.
     
113. Marcus AO. Safety of drugs commonly used to treat hypertension, dyslipidemia, and type 2 diabetes (the metabolic syndrome): Part 1. Diabetes Technol Ther 2000; 2:101 - 10.
     
114. Frier BM. Hypoglycaemia and cognitive function in diabetes. Int J Clin Pract 2001; (Suppl):30 - 7.